PMS2P8

Across TCGA pan-cancer cohorts, PMS2P8 RNA is linked to patient survival in 1 of 34 cancer types, making it the most broadly survival-associated PMS2P8 data layer.

The strongest signal is observed in lung adenocarcinoma (LUAD), where higher PMS2P8 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated PMS2P8 expression acts as an unfavorable survival marker.

LUAD are the cancer types where PMS2P8 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUAD	OS	Tertile	All	0.237	0.812	.001	45	view →

Pink = unfavorable, green = favorable. Showing the 1 strongest of 1 lineages.

PMS2P8–LUAD (OS)

Open the LUAD breakdown →